FDA, CMS scramble to avoid regulatory logjam as more states look to test AI in clinical settings
Overlapping state and federal roles complicate clinical AI pilots as Utah and federal agencies work on regulatory pathways.
TL;DR
- STAT reported that federal health officials are working to address overlapping state and federal jurisdiction over clinical AI.
- Utah has allowed clinical AI pilots under state oversight, while its AI office reported work with FDA and CMS on clinical pathways.
- The regulatory timetable and the allocation of responsibility remain open questions.
STAT reported that federal health officials are working behind the scenes on overlapping state and federal jurisdiction as clinical AI tools move into practice. States license clinicians, while the FDA regulates medical devices, creating a question over where AI performing clinical tasks fits. [1]
Nextgov/FCW reported that Utah announced 3 new health care AI pilots and had already allowed a Doctronic prescription-renewal pilot with clinician oversight. The state sandbox permits companies to test technologies under regulatory relief and state supervision. [2]
In a September 16 report presented to Utah lawmakers, the state’s AI office said FDA and CMS were working closely with it on clinical AI pathways. The office also listed overlap with federal rules among its regulatory concerns. [3]
Nextgov/FCW reported that Utah officials were still developing their approach to liability and independent oversight. The publicly readable portion of STAT’s report does not specify a timetable for resolving the federal-state questions. [1] [2]
Why it matters
For health AI developers and providers, state authorization and federal device oversight can affect the same deployment. The eventual allocation of responsibilities will shape how companies test and scale clinical products.
Editor's note
The accessible lead of the subscriber-only STAT report supports the attributed account of federal officials’ concerns. Nextgov/FCW provides independent reporting on Utah, and the state report documents agency collaboration; neither establishes a final federal resolution.